Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium

The North American Brain Tumor Consortium (NABTC) is a multi-institutional consortium with the primary objective of evaluating novel therapeutic strategies through early phase clinical trials. The NABTC has made substantial changes to the design and methodology of its trials since its inception in 1...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh P., DeAngelis, Lisa M., Lieberman, Frank S., Cloughesy, Timothy F., Robins, H. Ian, Abrey, Lauren E., Prados, Michael D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Duke University Press 2008
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2666238/
https://ncbi.nlm.nih.gov/pubmed/18559968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-021
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller